BENAVENTE, Y., G. MBISA, N. LABO, D. CASABONNE, N. BECKER, M. MAYNADIE, Lenka FORETOVÁ, Pierluigi COCCO, A. NIETERS, A. STAINES, P. BOFETTA, P. BRENNAN, D. WHITBY a S. DE SANJOSE. Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study. British Journal of Cancer. England: Nature Publishing Group, 2011, roč. 105, č. 11, s. 1768-1771. ISSN 0007-0920. Dostupné z: https://dx.doi.org/10.1038/bjc.2011.392. |
Další formáty:
BibTeX
LaTeX
RIS
@article{969148, author = {Benavente, Y. and Mbisa, G. and Labo, N. and Casabonne, D. and Becker, N. and Maynadie, M. and Foretová, Lenka and Cocco, Pierluigi and Nieters, A. and Staines, A. and Bofetta, P. and Brennan, P. and Whitby, D. and de Sanjose, S.}, article_location = {England}, article_number = {11}, doi = {http://dx.doi.org/10.1038/bjc.2011.392}, keywords = {epidemiology; Kaposi's sarcoma-associated herpes virus; human herpes virus 8; serology; lymphoma}, language = {eng}, issn = {0007-0920}, journal = {British Journal of Cancer}, title = {Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study}, volume = {105}, year = {2011} }
TY - JOUR ID - 969148 AU - Benavente, Y. - Mbisa, G. - Labo, N. - Casabonne, D. - Becker, N. - Maynadie, M. - Foretová, Lenka - Cocco, Pierluigi - Nieters, A. - Staines, A. - Bofetta, P. - Brennan, P. - Whitby, D. - de Sanjose, S. PY - 2011 TI - Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study JF - British Journal of Cancer VL - 105 IS - 11 SP - 1768-1771 EP - 1768-1771 PB - Nature Publishing Group SN - 00070920 KW - epidemiology KW - Kaposi's sarcoma-associated herpes virus KW - human herpes virus 8 KW - serology KW - lymphoma N2 - Kaposi's sarcoma-associated herpes virus is associated with primary effusion lymphoma and multicentric Castleman's disease. METHODS: Seropositivity to lytic and latent Kaposi's sarcoma herpes virus (KSHV) antigens were examined in 2083 lymphomas and 2013 controls from six European countries. RESULTS: Antibodies against KSHV latent and lytic antigens were detectable in 4.5% and 3.4% of controls, respectively, and 3.6% of cases (P>0.05). The KSHV seropositivity was associated with splenic marginal zone lymphoma (SMZL) (odds ratio (OR) = 4.11, 95% confidence interval (CI) 1.57-10.83) and multiple myeloma (OR = 0.31, 95% CI = 0.11-0.85). CONCLUSION: The KSHV is unlikely to contribute importantly to lymphomagenesis among immunocompetent subjects. However, the observed association with SMZL may underline a chronic antigen mechanism in its aetiology. ER -
BENAVENTE, Y., G. MBISA, N. LABO, D. CASABONNE, N. BECKER, M. MAYNADIE, Lenka FORETOVÁ, Pierluigi COCCO, A. NIETERS, A. STAINES, P. BOFETTA, P. BRENNAN, D. WHITBY a S. DE SANJOSE. Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study. \textit{British Journal of Cancer}. England: Nature Publishing Group, 2011, roč.~105, č.~11, s.~1768-1771. ISSN~0007-0920. Dostupné z: https://dx.doi.org/10.1038/bjc.2011.392.
|